Personalized and Predictive Insulin Dosing Across the Healthcare Enterprise
Monarch Medical Technologies, the maker of the EndoTool Glucose Management System, is the leading provider of precision insulin dosing technology for improved patient outcomes.
Interested in EndoTool?
Complete the form and a member of our team will be in contact to learn more about your glycemic management needs.
"*" indicates required fields
Precision Medicine for Inpatient Glycemic Management
Proven, patented algorithms that model, predict and adapt dosing recommendations to each patient and their individual response to insulin, for more precise, safer therapy.
Intravenous insulin dosing software to manage hyperglycemia while avoiding hypoglycemia
Basal-bolus subcutaneous insulin dosing software supporting industry guidelines and standards
Hospitals using EndoTool IV have demonstrated better patient outcomes, including:
See Why Customers Love EndoTool
Sandy Fogel, MD, FACS
Medical Director of OR Services, Carilion Clinic
Associate Professor of Surgery, Virginia Tech Carilion School of Medicine
"One of the things we really like about the software is that we’re able to achieve blood glucose control in a much improved time frame for very medically complex patients. This includes patients with significant renal impairment, patients who have been exposed to high doses of steroids, and multiple other conditions. The software is able to take into account a patient’s rapidly changing metabolic condition and accurately dose insulin in a safe way."
Gregory Deines, DO
Division Chief of Diabetes and Endocrinology, Spectrum Health
"EndoTool has not only reduced the risk of hypoglycemia, but also improved our compliance with managing hyperglycemia. Our hospital uses more insulin infusions than ever before because we feel confident in the dosing recommendations EndoTool provides. A key component of success is Monarch’s clinical support team who does an outstanding job training and supporting our facility continually throughout our many years with the software."
Maresa Glass, PharmD, BCCCP, FCCM
Assistant Director Clinical Services, Tampa General Hospital
"We currently treat all of our critical care patients on IV insulin with EndoTool and have seen great results with managing the glucose levels of our DKA patients. Our main concern for DKA patients on an insulin drip is to make sure that blood sugar levels do not decreased too quickly. However, after reviewing the DKA patient data where EndoTool was used, we have been very pleased with the outcomes."
Ron Fila, RPh
Clinical Pharmacist, McLaren Northern Michigan
WHY GLYCEMIC MANAGEMENT MATTERS
Learn why adopting best practices in glycemic management is vital to high-quality patient care.
Learn More
ENDOTOOL EVIDENCE LIBRARY
Explore clinical research studies demonstrating the safety and efficacy of EndoTool.
Learn More
Spotlight
Check out the latest news and resources from our internal teams and our users!
eBook
Spotlight on New CMS Measures for Inpatient Glycemic Quality
What are you doing to prepare? This eBook will help you understand high-level specifications for new CMS measures effective January 1, 2023 as well as a few key preplanning essentials to ensure a successful implementation.
EVIDENCE
Safety of EndoTool Versus Fixed-Dose Insulin Infusions for DKA or HHS in the Emergency Department
This retrospective study compares the safety of EndoTool glucose management software to a standard fixed-dose insulin infusion protocol for patients presenting to an emergency department with DKA or HHS.
Video
Spectrum Health Improves Inpatient Glucose Control with EndoTool
In this video, clinical leaders at Spectrum Health describe why they adopted a computer-based approach, the multidisciplinary team that evaluated options, and ultimately how EndoTool has helped improve patient care and essentially eliminate hypoglycemia.